Versartis

Latest articles

28d
FOX Business
Why Versartis, Wayfair, and Compass Minerals Slumped Todayinitiatives through Congress. Even though the market overall was flat, some sto
FOX Business / Posted 28 days ago
initiatives through Congress. Even though the market overall was flat, some stocks still fell sharply on downbeat news. Versartis (NASDAQ: VSAR), Wayfair (NYSE: W), and Compass Minerals (NYSE: CMP) were among the worst performers on the day.... Read more
28d
FOX Business
Why Versartis, Wayfair, and Compass Minerals Slumped Todayinitiatives through Congress. Even though the market overall was flat, some sto
FOX Business / Posted 28 days ago
initiatives through Congress. Even though the market overall was flat, some stocks still fell sharply on downbeat news. Versartis (NASDAQ: VSAR), Wayfair (NYSE: W), and Compass Minerals (NYSE: CMP) were among the worst performers on the day.... Read more
28d
Reuters
Wall St. flat as losses in healthcare offset gains in energythe company was close to agreeing tentative terms on a deal to merge with Sprin
Reuters / Posted 28 days ago
the company was close to agreeing tentative terms on a deal to merge with Sprint (S.N). Sprint shares jumped 4.48 percent. Versartis (VSAR.O) slumped more than 85 percent after its experimental drug for treatment of growth hormone deficiency in... Read more
4 related articles
28d
FOX Business
Wall St flat as losses in healthcare offset gains in energythe company was close to agreeing tentative terms on a deal to merge with Sprin
FOX Business / Posted 28 days ago
the company was close to agreeing tentative terms on a deal to merge with Sprint. Sprint shares jumped 4.48 percent. Versartis slumped more than 85 percent after its experimental drug for treatment of growth hormone deficiency in children... Read more
4 related articles
28d
FOX Business
Wall St flat as losses in healthcare offset gains in energythe company was close to agreeing tentative terms on a deal to merge with Sprin
FOX Business / Posted 28 days ago
the company was close to agreeing tentative terms on a deal to merge with Sprint. Sprint shares jumped 4.48 percent. Versartis slumped more than 85 percent after its experimental drug for treatment of growth hormone deficiency in children... Read more
4 related articles
28d
Reuters
Wall St. flat as North Korea tensions make investors risk-aversethe company was close to agreeing tentative terms on a deal to merge with Sprin
Reuters / Posted 28 days ago
the company was close to agreeing tentative terms on a deal to merge with Sprint (S.N). Sprint shares jumped 4.92 percent. Versartis (VSAR.O) slumped more than 85 percent after its experimental drug for treatment of growth hormone deficiency in... Read more
6 related articles
28d
FOX Business
Wall St flat as N.Korea tensions make investors risk-aversethe company was close to agreeing tentative terms on a deal to merge with Sprin
FOX Business / Posted 28 days ago
the company was close to agreeing tentative terms on a deal to merge with Sprint. Sprint shares jumped 4.92 percent. Versartis slumped more than 85 percent after its experimental drug for treatment of growth hormone deficiency in children... Read more
6 related articles
28d
FOX Business
Wall St flat as N.Korea tensions make investors risk-aversethe company was close to agreeing tentative terms on a deal to merge with Sprin
FOX Business / Posted 28 days ago
the company was close to agreeing tentative terms on a deal to merge with Sprint. Sprint shares jumped 4.92 percent. Versartis slumped more than 85 percent after its experimental drug for treatment of growth hormone deficiency in children... Read more
6 related articles
28d
Market Watch
Ascendis Pharma shares surge 42% as competitor Versartis plummets 85% on failed trialPharma shares surged 42% in premarket trade Friday after news that a late-stage
Market Watch / Posted 28 days ago
Pharma shares surged 42% in premarket trade Friday after news that a late-stage clinical trial conducted by competitor Versartis Inc. failed. Both companies are developing human growth hormone therapies for children with deficiencies of the... Read more
28d
Reuters
Wall Street set for lower open as North Korea tensions mountthe company was close to agreeing tentative terms on a deal to merge with Sprin
Reuters / Posted 28 days ago
the company was close to agreeing tentative terms on a deal to merge with Sprint (S.N). Sprint shares jumped 4 percent. Versartis (VSAR.O) tanked about 85 percent after its experimental drug for treatment of growth hormone deficiency in children... Read more
6 related articles
28d
Reuters
Futures slightly lower as U.S.-North Korea tensions escalatepercent in premarket trading, as the launch of iPhone 8 kicked off in a less li
Reuters / Posted 28 days ago
percent in premarket trading, as the launch of iPhone 8 kicked off in a less lively mood in Asia versus previous debuts. * Versartis (VSAR.O) tanked about 84 percent after its experimental drug for treatment of growth hormone deficiency in children... Read more
6 related articles
28d
FOX Business
Futures slightly lower as US-N.Korea tensions escalatepercent in premarket trading, as the launch of iPhone 8 kicked off in a less li
FOX Business / Posted 28 days ago
percent in premarket trading, as the launch of iPhone 8 kicked off in a less lively mood in Asia versus previous debuts. * Versartis tanked about 84 percent after its experimental drug for treatment of growth hormone deficiency in children failed... Read more
6 related articles
28d
FOX Business
Futures slightly lower as US-N.Korea tensions escalatepercent in premarket trading, as the launch of iPhone 8 kicked off in a less li
FOX Business / Posted 28 days ago
percent in premarket trading, as the launch of iPhone 8 kicked off in a less lively mood in Asia versus previous debuts. * Versartis tanked about 84 percent after its experimental drug for treatment of growth hormone deficiency in children failed... Read more
53 related articles
28d
Channel NewsAsia
Futures slightly lower as US-North Korea tensions escalatepercent in premarket trading, as the launch of iPhone 8 kicked off in a less li
Channel NewsAsia / Posted 28 days ago
percent in premarket trading, as the launch of iPhone 8 kicked off in a less lively mood in Asia versus previous debuts. * Versartis tanked about 84 percent after its experimental drug for treatment of growth hormone deficiency in children failed... Read more
6 related articles
29d
Channel NewsAsia
Versartis growth hormone drug fails key study, shares sinkREUTERS: Versartis Inc said its experimental drug for the treatment of growth h
Channel NewsAsia / Posted 29 days ago
REUTERS: Versartis Inc said its experimental drug for the treatment of growth hormone deficiency in children did not meet the main goal of a late-stage study, sending its shares tanking 85 percent. The drug, somavaratan, is a long-acting recombinant... Read more
1m
Business Wire
Moncef Slaoui Joins Medicxibacked many successful companies, including Genmab (NASDAQ Copenhagen: GEN), Pa
Business Wire / Posted a month ago
backed many successful companies, including Genmab (NASDAQ Copenhagen: GEN), PanGenetics (sold to AbbVie), Molecular Partners (SWX: MOLN), XO1 (sold to Janssen) Egalet (NASDAQ: EGLT), Minerva Neurosciences (NASDAQ: NERV) and Versartis (NASDAQ: VS... Read more

In this news